Importance Several management strategies may improve outcomes in patients
withStaphylococcus aureusbacteremia. Objectives To review evidence of management …

Enterococci, one of the most common causes of hospital-associated infections, are
responsible for substantial morbidity and mortality. Enterococcus faecalis, the more common …

Daptomycin is a lipopeptide antimicrobial with in vitro bactericidal activity against Gram-
positive bacteria that was first approved for clinical use in 2004 in the United States. Since …

Resistance trends have changed greatly over the 14 years (1997–2011) whilst I was
Director of the UK Antibiotic Resistance Monitoring and Reference Laboratory (ARMRL) …

Treatment of multidrug-resistant enterococci has become a challenging clinical problem in
hospitals around the world due to the lack of reliable therapeutic options. Daptomycin (DAP) …

Background. Recent reports have described decreased effectiveness with vancomycin
treatment for methicillin-resistant Staphylococcus aureus bacteremia (MRSAB) when the …

Urinary tract infection (UTI) represents the most common infection after kidney
transplantation; it is associated with an increased risk for acute kidney rejection and …

Abstract Background. Vancomycin-resistant Enterococcus bloodstream infections (VRE-
BSIs) are becoming increasingly common. Linezolid and daptomycin are the primary …

This review is the result of discussions that took place at the 5th MRSA Working Group
Consensus Meeting and explores the possible treatment options available for different types …

Staphylococcus aureus is a major cause of nosocomial and community‐acquired infections
and contributes to significant increase in morbidity and mortality especially when associated …